Taking on biodefense threats, antibiotics maker Spero inks $54M in government deals

Taking on biodefense threats, antibiotics maker Spero inks $54M in government deals

Source: 
Endpoints
snippet: 

Cambridge, Massachusetts startup Spero Therapeutics is joining forces with US defense organizations to see if their investigational antibiotic could be useful against biodefense threats.